Sales
- Up 8.7% at constant exchange rates
- Of which 2.9% through organic growth
- bioMérieux China becomes the Group's 3rd largest company, with sales up 48%*
- Solid 22%* growth in sales of the Full Microbiology Lab Automation (FMLA®) range
- Confirmed strong momentum in industrial applications, up 8.2%*
* At constant exchange rates and comparable business base
Download
- Filename
- pr_biomerieux_q2_2012_sales.pdf
- Size
- 307 KB
- Format
- application/pdf